FDA inspection

Bioreliance Ltd.: FDA inspection ending Nov 7, 2023

FDA inspection 1223799 · No Action Indicated (NAI) · Stirling, Scotland

Key facts

Inspection ID 1223799
Firm Bioreliance Ltd.
FEI number 3005619549
Address Scotland, Hillfoots Road; Innovation Park
City Stirling, Scotland
Country United Kingdom
Fiscal year 2024
Inspection end date Nov 7, 2023
Classification No Action Indicated (NAI)
Project area Vaccines and Allergenic Products
Product type Biologics

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections